rTMS for Depression in Young Adults With Autism
RecruitingNCT04972136Phase: NAStarted 2021-01-14
Summary
The current clinical trial is focused on evaluating the efficacy of rTMS for treatment of depression in youth and young adults (hereafter called transition aged youth, TAY) with autism spectrum disord
Eligibility
Sex
ALL
Min Age
16 Years
Max Age
35 Years
Locations
Centre for Addiction and Mental HealthToronto, Ontario, Canada
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT04972136